Skip to main content
BioPlus Co., Ltd logo

BioPlus Co., Ltd — Investor Relations & Filings

Ticker · 099430 ISIN · KR7099430001 KO Manufacturing
Filings indexed 226 across all filing types
Latest filing 2025-01-07 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 099430

About BioPlus Co., Ltd

https://ubioplus.com/

BioPlus Co., Ltd. is a company that researches, develops, and manufactures biomaterials, with a primary focus on hyaluronic acid (HA) applications. The company's core competency is its proprietary MDM® Technology, which is used to create a diverse product portfolio for the beauty and healthcare industries. Key products include a range of dermal and body fillers, skin boosters, anti-adhesion agents, biomaterial breast implants, and artificial cartilage. The company aims to provide bio-therapy solutions by addressing fundamental cellular-level issues through its advanced technologies.

Recent filings

Filing Released Lang Actions
[기재정정]전환주식의전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (BioPlus) regarding the exercise of conversion rights for convertible preferred shares into common shares. It details the number of shares, conversion ratios, and changes in capital structure. This type of filing, which involves the issuance of new shares resulting from the conversion of existing securities, falls under the 'Share Issue/Capital Change' category.
2025-01-07 Korean
전환주식의전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Bioplus) regarding the exercise of conversion rights for convertible preferred shares into common shares. This results in a change in the company's capital structure (increase in common shares, decrease in preferred shares). According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2025-01-03 Korean
[기재정정]신규시설투자등
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Bioplus regarding a 'Correction Report' (정정신고) for a 'New Facility Investment' (신규시설투자). It details changes to the investment period end date and provides specific financial data related to capital expenditure. Since this is a formal regulatory disclosure regarding corporate capital investment and its amendment, it falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A or Share Issues.
2024-12-31 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document details changes in share ownership (specifically involving Lindeman Asia Investment Corp and its related funds) in the company 'BioPlus Co., Ltd.' due to conversion price adjustments and call option exercises. This falls under the category of Major Shareholding Notification.
2024-12-30 Korean
자기주식취득결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a '자기주식취득결과보고서' (Report on the Results of Treasury Stock Acquisition) filed with the Financial Supervisory Service (FSS) in South Korea. It details the specific quantity, price, and dates of the company's own share acquisition. According to the provided definitions, reports regarding a company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2024-12-26 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal notice of the procedural steps for the meeting. Given the nature of the announcement as a regulatory disclosure of corporate action, it fits best under the RNS category.
2024-12-16 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.